Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study

Authors:
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • Beijing Talents Fund (2014000021223ZK26)
  • Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201603)
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z151100003915074)
  • Bayer Pharmaceuticals

This publication has 26 references indexed in Scilit: